Development of salvianolic acid B-tanshinone IIA-glycyrrhetinic acid compound liposomes: Tissue distribution in vivo of mice and evaluation of the liver targeting
单位：[1]Beijing Univ Chinese Med, Sch Chinese Pharm, Beijing, Peoples R China[2]China Japan Friendship Hosp, Natl Integrat Med Ctr Cardiovasc Dis, Beijing, Peoples R China
第一作者单位：[1]Beijing Univ Chinese Med, Sch Chinese Pharm, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Wang Xiuli,Lin Jiahao,Li Geng,et al.Development of salvianolic acid B-tanshinone IIA-glycyrrhetinic acid compound liposomes: Tissue distribution in vivo of mice and evaluation of the liver targeting[J].NANOMEDICINE-NANOTECHNOLOGY BIOLOGY and MEDICINE.2016,12(2):497-497.doi:10.1016/j.nano.2015.12.145.
APA：
Wang, Xiuli,Lin, Jiahao,Li, Geng,Qiu, Minyue&Wang, Yurong.(2016).Development of salvianolic acid B-tanshinone IIA-glycyrrhetinic acid compound liposomes: Tissue distribution in vivo of mice and evaluation of the liver targeting.NANOMEDICINE-NANOTECHNOLOGY BIOLOGY and MEDICINE,12,(2)
MLA：
Wang, Xiuli,et al."Development of salvianolic acid B-tanshinone IIA-glycyrrhetinic acid compound liposomes: Tissue distribution in vivo of mice and evaluation of the liver targeting".NANOMEDICINE-NANOTECHNOLOGY BIOLOGY and MEDICINE 12..2(2016):497-497
工程技术